Sharma, Ritika
Frasch, Martin G.
Zelgert, Camila
Zimmermann, Peter
Fabre, Bibiana
Wilson, Rory
Waldenberger, Melanie
MacDonald, James W.
Bammler, Theo K.
Lobmaier, Silvia M.
Antonelli, Marta C.
Funding for this research was provided by:
Technische Universität München
Article History
Received: 6 February 2022
Accepted: 5 July 2022
First Online: 14 July 2022
Declarations
:
: The study protocol is in strict accordance with the Committee of Ethical Principles for Medical Research from TUM and has the approval of the ‘Ethikkommission der Fakultät für Medizin der Technische Universität München’ (registration number 151/16S). ClinicalTrials.gov registration number is NCT03389178. Written informed consent was received from participants prior to inclusion in the study.
: Not applicable.
: MGF holds a pending US patent on fetal ECG technology (20210330236); US patent on fetal EEG (9215999), equity in Delfina and Vitalink AI. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.